In the current study of Mycobacterium tuberculosis (MTB)-specific T and B cells, we found that MTB-specific peptides from early secreted antigenic target-6 (ESAT-6) and culture fil- 
Introduction
Tuberculosis (TB) is one of the most ancient diseases of mankind and currently remains a leading cause of death from infectious disease worldwide [1] [2] [3] . The incidence of TB has increased over the past few years for reasons such as inadequate preventative efforts, incorrect or inappropriate medication, the emergence of drug-resistant strains of Mycobacterium tuberculosis (MTB) and the prevalence of human immunodeficiency virus (HIV) infection [4] [5] [6] . Cell-mediated immunity is known to be crucial for protection against TB and most studies have shown that CD4 + and CD8 + T cells are essential for protective immunity [7] [8] [9] [10] . We have been committed to studying MTB-specific effector and memory CD4 + T cells, including Th1, Th17, and Th22 cells [11, 12] , and we have identified the epitopes, functions and regulation of CD8 + T cells against MTB infection [13, 14] . Recently, we found that pleural fluid cells (PFCs)
secrete IL-21 following stimulation with specific peptides. IL-21, a potent immunomodulatory cytokine, has pleiotropic effects on both innate and adaptive immune responses [15] [16] [17] . Owing to the broad cellular distribution of the IL-21 receptor, IL-21 exerts pleiotropic effects on the immune system [16, 18] . The role of IL-21 in sustaining and regulating T cell, B cell, and NK cell responses during autoimmune diseases, chronic infectious diseases and immunodeficiency diseases has recently come into focus [17, 19, 20] .
It has been reported that follicular helper T (Tfh) cells, Th17 cells, NKT cells, Th1 cells and Th2 cells can produce IL-21, although Tfh cells have the closest relationship with IL-21 [21] [22] [23] [24] . In addition, activated human dendritic cells have been shown to induce naïve CD4 + T cells to become IL-21-expressing Tfh-like cells through IL-12 [25] . Tfh cells in humans were initially described in 2000 and 2001, when several groups reported that a large proportion of CD4 + T cells in tonsils have a unique phenotype and express high levels of chemokine (C-X-C motif) receptor 5 (CXCR5) [24] . Currently, Tfh cells are considered to be a distinct CD4 + T cell type and they are important for protective immunity [24, 26] . Those cells are characterized by expression of the transcription factor B-cell lymphoma 6 (Bcl-6), production of high amounts of the B-cell stimulatory cytokine IL-21, and increased levels of CXCR5, inducible costimulator (ICOS) and programmed death 1 (PD-1) [24, 26, 27 ].
In the current study, we tried to define the relationship between MTB-specific IL-21-expressing cells and Tfh cells. We conducted studies to determine the immunophenotypical characteristics, functional properties and regulatory factors of MTB-specific IL-21-expressing CD4 + T cells. Our data demonstrated that MTB-specific IL-21-expressing CD4 + T cells are present at local sites of infection in patients with tuberculous pleurisy (TBP) and these cells may play an important role in local cellular immunity against TB infection.
Results

MTB-specific peptides induce IL-21 production by PFCs
To determine whether the MTB-specific peptides ESAT-6 and CFP-10 (E/C) induce IL-21 production, PFCs were cultured in the presence of medium alone, E/C peptides, or PMA plus ionomycin. RT-PCR results revealed that E/C peptides induce markedly higher levels of IL-21 mRNA transcription than cultures with medium alone. As expected, PMA plus ionomycin also induced significantly high levels of IL-21 ( Fig 1A and 1B) . To further analyze the frequency of IL-21-producing cells, an enzyme-linked immunospot (ELISPOT) assay was conducted. IL-21 + spots were not detectable without stimulation. E/C peptides, however, elicited a strong antigenspecific T cell response with an average of 71 spot-forming cells (SFCs) (range, 57-108 SFCs), which was significantly higher than in medium alone (Fig 1C and 1D) . PMA plus ionomycin induced a stronger response. Altogether, these results indicated that E/C peptides induced IL-21 production by PFCs at both mRNA and protein levels.
CD4 + T cells from PFCs express IL-21 following stimulation with E/C peptides
To further determine which subsets of cells produce IL-21, fluorescence-activated cell sorting (FACS) was conducted. The results showed a very low frequency of IL-21 expression by PFCs in the presence of medium alone. Following stimulation with E/C peptides, CD4 + T cells, but not CD8 + T cells, expressed IL-21 (Fig 2A and 2B) . Notably, PMA plus ionomycin induced To further determine whether cytokines regulate MTB-specific IL-21 production by PFCs, an ELISPOT assay was conducted. No or few IL-21 + spots were formed without stimulation or in the presence of cytokine alone. However, E/C peptides or E/C peptides plus cytokine elicited strong antigen-specific IL-21 production (Fig 7A) . Importantly, more IL-21 + spots were
formed following E/C peptides plus IL-12 stimulation than stimulation with E/C peptides alone. However, IL-6 and IL-27 did not have an effect (Fig 7B) . To confirm these results, we conducted FACS. Consistent with the ELISPOT results, medium and cytokine alone did not induce IL-21 production. However, both the E/C peptides and the E/C peptide plus cytokine conditions induced IL-21 production (Fig 8A) . Significantly higher levels of IL-21 were induced by the combination of IL-12 and E/C peptides when compared with E/C peptides alone (Fig 8B) . To specifically analyze which cell subset was regulated, the expression of IL-21 and IFN-γ was analyzed on the CD4 + T cell gate (Fig 8C) . Analysis of cytokine-expressing CD4 + T cells indicated that the subset of IL-21 + IFN-γ + cells was markedly enhanced following the addition of IL-12 compared with E/C peptides alone, but no significant difference was observed with respect to the subset of IL-21 + IFN-γ -or IL-21 -IFN-γ + cells (Fig 8D) . Taken together, these results indicated that IL-12, but not IL-6, IL-27, or IL-21, promotes MTB-specific IL-21 production by PFCs.
Discussion
It is well known that MTB-specific CD4 + T cells are critical for protection against TB [28] . In the past few years, we published our efforts in determining the phenotype, function, and regulation of MTB-specific CD4 + T cells. Currently, we found that IL-21 was induced by PFCs at [33] . Moreover, other studies have found that IL-21 is produced by NKT cells [22] . Recently, our studies have also demonstrated for the first time that IL-21 could be produced by NKT cells in TB infection following stimulation with MTB-specific antigens [34] . However, little data exists characterizing the production and regulation of IL-21-expressing CD4 + T cells during tuberculosis. These discrepancies of cell sources of IL-21 production might be due to differences in species, stimuli, or stimulation conditions. Next, we examined the correlation of IL-21 with other cytokines, and we found that the subset of MTB-specific IL-21-expressing CD4 + T cells was different from the Th1, Th2, and Th17 subpopulations. A fraction of IL-21-expressing cells simultaneously produced Th1 cytokines, but not Th2 or Th17 cytokines. In support of these results, environmental factors that change the ratio of Bcl-6 to T-bet in Th1 cells may cause variability in Th1 and Tfh-like gene-expression patterns [35, 36] . It is well known that IL-21 is a marker for Tfh cells [24, 26] . However, IL-21-producing cells cannot be classified as Tfh cells because other cell types can express substantial amounts of IL-21. In addition to the expression of IL-21, some important markers, such as ICOS, CXCR5, PD-1, as well as Bcl-6, are also critical in the identification of Tfh cells [24, 26, 27] . Therefore, we examined the phenotype of CD4 + IL-21 + T cells. Our study showed that, in concordance issue that requires more examination [37, 38] . Recently, decreased frequencies of CD4 + CXCR5 + T helper cells were reported in the blood of active pulmonary TB patients when compared with 
Materials and Methods
Ethics statement
Informed written consent was obtained from all patients. The study protocol was approved by the Ethics Committee of the Zhongshan School of Medicine, Sun Yat-sen University (Guangzhou, China) and the Chest Hospital of Guangzhou (Guangzhou, China).
Study participants
Thirty patients infected with Mycobacterium tuberculosis (12 females and 18 males, age 23 to 74 years old) were recruited into the study. All patients were newly diagnosed with TB pleurisy at the Chest Hospital of Guangzhou, China. Diagnosis of the patients was confirmed by the following criteria: positive cultures for MTB in cultures of pleural biopsy specimens or pleural fluid smear, histological evidence in biopsy specimens of pleural tissue, and positive staining for MTB. Patients who had been previously diagnosed with HIV, hepatitis B, or hepatitis C, or who had a history of autoimmune diseases, were excluded from the study. All pleurisy samples were collected before the initiation of anti-tuberculosis treatment.
Antigens and mAbs
We selected six highly immunogenic peptides, which are largely human leukocyte antigen (HLA)-DR-restricted. Four peptides were derived from ESAT-6 and two were from the CFP-10 protein of MTB. Synthetic peptides were obtained from Shenzhen Hanyu manufacture, Shenzhen, China. The amino acid sequences of the peptides were previously described [11, 12] . Lyophilized peptides were reconstituted in DMSO and stored at -80°C. Anti-CD28 (clone CD28.2) and anti-CD49d (clone 9F10) mAbs were purchased from BD Biosciences Pharmingen (San Jose, CA). The following mAbs were purchased from BD Pharmingen (San Jose, CA, USA) and were used for phenotypic, intracellular cytokine, and transcription factor analysis: CD3-PE-cy7 (SK7), CD3-PE-CF594 (UCHT1) 
Preparation of PFCs
Pleural fluid was obtained by thoracocentesis from tuberculosis patients. PFCs were isolated by lysing erythrocytes with an ammonium chloride solution and resuspended to a final concentration of 2×10 6 cells/mL in complete RPMI-1640 medium (Invitrogen, Grand Island, NY, USA)
supplemented with 10% heat-inactivated fetal calf serum (FCS; Sijiqing, Hangzhou, China), 100 U/mL penicillin, 100 μg/mL streptomycin, 2 mM L-glutamine, and 50 μM 2-mercaptoethanol (all from Gibco BRL).
